Sequent Medical CEO Tom Wilder tells MassDevice.com why his company's MicroBraid technology is a key differentiator in its Web device for treating brain aneurysms and, potentially, other conditions.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1rMBgqq
Cap comentari:
Publica un comentari a l'entrada